Developer docs
API playgroundTry for free, no card

Search company profiles

Aegis Ventures

Full company profile

uuid0003u1l

Namestring
Aegis Ventures
Legal namestring
Aegis Ventures
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Aegis Ventures is a New York-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems (the Aegis Digital Consortium), representing over $100B in collective annual revenue. Founded in 2021 by Bill Schoenfeld (Chairman and CEO of APL Group, the founding investor and sponsor) and John Beadle (Managing Partner), the studio has launched six portfolio companies to date: Wavelet Medical (non-invasive AI-powered fetal EEG brain monitoring), Optain Health (AI retinal screening and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companion platform), Avandra (federated real-world medical imaging data network), and Ascertain (AI agent platform for healthcare workflow automation). The studio reports a 100% seed-to-Series A conversion rate across its portfolio, with $200M+ collectively raised by portfolio companies including a $26M Series A for Optain led by Insight Partners (September 2025) and a $7M seed for Wavelet (April 2026).

The studio's core technology is its venture studio model, which combines deep healthcare insights, aligned capital deployment, and proprietary customer access through the health system consortium to increase company creation velocity. Portfolio companies deploy proprietary AI across multiple modalities — computer vision (Optain retinal imaging, Wavelet fetal EEG signal processing), speech and audio (Hume EVI emotion analysis), autonomous agents (Caregentic, Ascertain), and structured data platforms (Avandra). The studio maintains an enterprise field sales go-to-market motion with no self-serve or consumer distribution; portfolio companies sell exclusively through direct enterprise contracts with health systems and healthcare organizations, often leveraging consortium relationships for clinical validation, early adoption, and deployment at scale.

Aegis's business model is venture studio equity ownership — the studio co-founds companies, provides operational expertise and capital, and realizes returns through portfolio company exits. Revenue is not publicly disclosed. The company is privately held, with APL Group (parent) as founding investor and Bill Schoenfeld as the largest shareholder. The leadership team includes David Feinberg, MD (Executive Chairman, former head of UCLA Health, Geisinger, Google Health, and current Oracle Health Chairman), John Noseworthy, MD (Chairman of the Digital Consortium and Venture Partner, former Mayo Clinic CEO), and multiple Venture Partners from Mayo Clinic, Apple Healthcare, McKinsey, and Walgreens Boots Alliance. The studio reports global portfolio company deployment across the U.S., South Korea, EU, UK, Australia, and New Zealand, and is recognized in Digital Health Insider's 2025 Top VCs in Healthcare ranking.

Short descriptiontext

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems. It has launched six portfolio companies spanning fetal monitoring, retinal screening, voice AI, patient engagement, imaging data, and workflow automation, reporting $200M+ in collective portfolio capital raised.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture studio, healthtech investing, AI healthcare startups, digital health consortium, portfolio company creation
Industry4 codes
PRIMARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAI
Corporate Innovation & Technology Scouting Units (with investment mandate)
SECONDARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Software Publishers5132
SIC code2 codes
  • Investment Advice6282
  • Services-Management Consulting Services8742
Product category
venture studio services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Studio / Equity Ownership
TypeSubscription Recurring
Description

Aegis Ventures generates returns through equity ownership in portfolio companies it co-founds and scales. The studio model combines capital, operational expertise, and health system partnerships to accelerate portfolio companies from seed through Series A, with 100% seed-to-Series A conversion rate cited. Returns are realized through portfolio company exits.

aegisventures.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1Wavelet
Description

AI-powered fetal brain monitoring platform enabling real-time detection of neurological distress in fetuses through non-invasive EEG technology.

aegisventures.com
+5 more records
Core offering1 text field

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies. It combines deep healthcare insights, aligned capital, and proprietary customer access through a consortium of 14 leading health systems (the Aegis Digital Consortium) to co-create portfolio companies. The studio has launched six portfolio companies spanning disease detection, workflow automation, patient engagement, and real-world data, and reports a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 10 values shown
  • 100% seed to Series A conversion across 5 portfolio companies launched
+9 more records
Product overview1 text field

Aegis Ventures is a NYC-based venture studio that builds AI-native healthtech companies. The company operates a portfolio of six distinct AI-powered healthcare products: Wavelet Medical (non-invasive fetal brain monitoring via EEG), Optain Health (AI retinal imaging and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companions), Avandra (real-world imaging data network), and Ascertain (workflow automation AI). These products collectively address disease detection, patient engagement, data monetization, and operational efficiency across healthcare settings.

Product and service6 records
1Aegis Ventures Venture Studio
Categoryventure_studio
Description

NYC-based venture studio that combines deep healthcare insights, aligned capital, and proprietary access to customers through the 14-health-system Aegis Digital Consortium to build and scale AI-native healthtech companies. The studio reports having launched six portfolio companies and a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies collectively.

2Optain Health
Categoryportfolio_company
Description

AI-backed retinal screening platform that combines AI, retinal imaging, and oculomics to enable non-invasive, rapid assessment of eye and cardiovascular conditions. Detects diabetic retinopathy, glaucoma, macular degeneration, and CVD with >90% accuracy across 10+ diseases in under 60 seconds, deployed across US, EU, UK, Australia, and New Zealand.

3Hume AI
Categoryportfolio_company
Description

Emotionally intelligent voice AI platform that analyzes vocal emotional signals in real time and adapts tone to respond with expressive, lifelike speech. Empathic Voice Interface (EVI) and Octave text-to-speech engine power emotionally aware voice interactions for mental health, customer service, education, and conversational AI.

4Caregentic
Categoryportfolio_company
Description

GenAI companion platform that serves as a 24/7 extension of care teams, deploying autonomous AI agents that execute complex clinical and administrative workflows including appointment scheduling, billing questions, care journey navigation, and clinical support via SMS, phone, and web, integrated with EHR systems.

5Avandra
Categoryportfolio_company
Description

Real-world imaging data platform that enables compliant access to high-quality, standardized imaging (CT, MRI, PET, Ultrasound) from leading health systems to accelerate AI model development for pharma, biotech, and medical AI developers.

6Ascertain
Categoryportfolio_company
Description

AI agents platform that automates healthcare workflows, transforms operations, and ushers in the workforce of the future for healthcare administration and prior authorization.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-14
Description

Aegis Ventures entered a co-creation partnership with Wavelet Medical to commercialize a non-invasive, AI-powered fetal EEG monitoring platform developed at Yale. The partnership aims to scale the technology globally, with clinical trials underway at three U.S. sites. Wavelet Medical is a portfolio company spun out of Yale with $7M in seed funding.

Strategic tierKeyTypeOthersAnnounced on2026-04-06
Description

Bunny Ellerin appointed as Chief Ecosystem Officer at Aegis Ventures. She leads end-to-end founder and ecosystem development, sourcing top entrepreneurial talent, building the EIR and operator network, and driving strategic relationships across healthcare. Previously co-founded and led Digital Health New York (DHNY).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Northwell Health is a core member of the Aegis Digital Consortium, collaborating to advance healthcare innovation by combining leading clinical, technology, and business resources. Northwell works with Aegis to fast-track creation of validated solutions that solve important challenges across the enterprise and can be replicated with health systems across the country.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Memorial Hermann views innovation as a disciplined pathway to solve real operational and clinical problems. The Aegis Digital Consortium provides a valuable forum for pragmatic insight-sharing and peer learning among health systems, helping shape scalable solutions to shared challenges.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Indiana University Health participates in the Aegis Digital Consortium to partner with like-minded health systems in building and investing in new solutions at scale. Together they address common problems and create new businesses that will transform healthcare.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Endeavor Health has a rigorous intake requirement which Aegis consistently meets. They are adopting, piloting, or co-developing with most of the portfolio companies and have swapped out incumbents for Aegis solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

UPMC Enterprises' partnership with the Digital Consortium enables building deep relationships with peer health system leaders, navigating healthcare challenges together, and collaborating to develop meaningful solutions and scale innovative companies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

OSU Wexner's mission to drive innovative healthcare transformation aligns with the Aegis Digital Consortium. Through the consortium, they collaborate with other health systems to develop new solutions to help solve challenges facing the healthcare industry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused venture studio that has launched 50+ healthcare companies. Directly comparable to Aegis in model (studio, not fund), vertical focus (healthcare), and company-creation approach, though Redesign has broader sector coverage and a larger capital base.

TypeBroad incumbent
Description

Major venture firm with deep healthcare focus (Health Assurance thesis, committed $750M+ to healthcare) and a creation-oriented approach. Overlaps with Aegis in healthcare AI investment and in working closely with health systems, but operates primarily as a traditional fund rather than a studio.

TypeBroad incumbent
Description

Tier-1 venture firm with a dedicated Bio/Health fund. Competes with Aegis for healthcare AI founder relationships and portfolio investments; offers founders brand prestige and large check sizes that the studio model must counter with embedded customer access.

TypeBroad incumbent
Description

Corporate venture arm of UnitedHealth Group focused on healthcare AI and digital health. Comparable in healthcare vertical and willingness to co-create with health system customers; competes for the same founder pool and AI-health deals.

TypeBroad incumbent
Description

Large venture firm with significant healthcare and AI exposure. Competes for healthcare AI deal flow and offers founders a different value proposition (broad sector network vs. Aegis's vertical healthcare studio model with health system consortium).

TypeBroad incumbent
Description

Science and technology-focused venture firm with healthcare AI portfolio (including AI-native healthtech companies). Comparable in backing technical founders in healthcare AI; differs from Aegis's venture-studio structure and health-system consortium model.

TypeDirect peer
Description

Venture studio that builds and funds companies from inception across multiple sectors. Directly comparable studio model to Aegis, though Atomic is more generalist in sector focus and lacks Aegis's healthcare-vertical depth and health system consortium.

TypeDirect peer
Description

Global venture studio that builds startups in partnership with corporates. Comparable studio model to Aegis with corporate-partner-led company creation; differs in sector focus (broader) and lacks Aegis's healthcare-specialized health system consortium.

TypeEmerging player
Description

Healthtech-focused venture firm investing in AI-enabled healthcare companies. Comparable healthcare-vertical focus and AI-native investment thesis; differs from Aegis in operating as a traditional fund rather than a venture studio.

TypeEmerging player
Description

Healthcare-focused venture firm investing in early-stage healthtech and digital health companies. Comparable in healthcare vertical and early-stage focus; differs from Aegis's studio model with embedded health system consortium.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability11 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment10 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aegis Ventures

venture studio servicesaegisventures.com

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems. It has launched six portfolio companies spanning fetal monitoring, retinal screening, voice AI, patient engagement, imaging data, and workflow automation, reporting $200M+ in collective portfolio capital raised.

What Aegis Ventures does

Aegis Ventures is a New York-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems (the Aegis Digital Consortium), representing over $100B in collective annual revenue. Founded in 2021 by Bill Schoenfeld (Chairman and CEO of APL Group, the founding investor and sponsor) and John Beadle (Managing Partner), the studio has launched six portfolio companies to date: Wavelet Medical (non-invasive AI-powered fetal EEG brain monitoring), Optain Health (AI retinal screening and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companion platform), Avandra (federated real-world medical imaging data network), and Ascertain (AI agent platform for healthcare workflow automation). The studio reports a 100% seed-to-Series A conversion rate across its portfolio, with $200M+ collectively raised by portfolio companies including a $26M Series A for Optain led by Insight Partners (September 2025) and a $7M seed for Wavelet (April 2026).

The studio's core technology is its venture studio model, which combines deep healthcare insights, aligned capital deployment, and proprietary customer access through the health system consortium to increase company creation velocity. Portfolio companies deploy proprietary AI across multiple modalities — computer vision (Optain retinal imaging, Wavelet fetal EEG signal processing), speech and audio (Hume EVI emotion analysis), autonomous agents (Caregentic, Ascertain), and structured data platforms (Avandra). The studio maintains an enterprise field sales go-to-market motion with no self-serve or consumer distribution; portfolio companies sell exclusively through direct enterprise contracts with health systems and healthcare organizations, often leveraging consortium relationships for clinical validation, early adoption, and deployment at scale.

Aegis's business model is venture studio equity ownership — the studio co-founds companies, provides operational expertise and capital, and realizes returns through portfolio company exits. Revenue is not publicly disclosed. The company is privately held, with APL Group (parent) as founding investor and Bill Schoenfeld as the largest shareholder. The leadership team includes David Feinberg, MD (Executive Chairman, former head of UCLA Health, Geisinger, Google Health, and current Oracle Health Chairman), John Noseworthy, MD (Chairman of the Digital Consortium and Venture Partner, former Mayo Clinic CEO), and multiple Venture Partners from Mayo Clinic, Apple Healthcare, McKinsey, and Walgreens Boots Alliance. The studio reports global portfolio company deployment across the U.S., South Korea, EU, UK, Australia, and New Zealand, and is recognized in Digital Health Insider's 2025 Top VCs in Healthcare ranking.

Aegis Ventures firmographics

Firmographics
Name
Aegis Ventures
Legal name
Aegis Ventures
Website
https://aegisventures.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies in partnership with a consortium of 14 leading U.S. health systems. It has launched six portfolio companies spanning fetal monitoring, retinal screening, voice AI, patient engagement, imaging data, and workflow automation, reporting $200M+ in collective portfolio capital raised.
Ownership category
akta.pro rank

Aegis Ventures industry classification

Industry
Product category
venture studio services
NAICS
Portfolio Management and Investment Advice (52394), Software Publishers (5132)
SIC
Investment Advice (6282), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYFSANAHAC
Corporate Venture Studios & Incubators (Build/launch ventures)
SECONDARYFSANAHAI
Corporate Innovation & Technology Scouting Units (with investment mandate)
SECONDARYFSANAHAF
Corporate Strategic Partnership & Ecosystem Investment Arms
SECONDARYBPAEAHAF
AI/ML Engineering & Model Development Services

Keywords

  • Venture studio
  • Healthtech investing
  • AI healthcare startups
  • Digital health consortium
  • Portfolio company creation

Where Aegis Ventures is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Aegis Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

  1. Venture Studio / Equity Ownership: Aegis Ventures generates returns through equity ownership in portfolio companies it co-founds and scales. The studio model combines capital, operational expertise, and health system partnerships to accelerate portfolio companies from seed through Series A, with 100% seed-to-Series A conversion rate cited. Returns are realized through portfolio company exits.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Aegis Ventures product offering

Product offering

Core offering

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies. It combines deep healthcare insights, aligned capital, and proprietary customer access through a consortium of 14 leading health systems (the Aegis Digital Consortium) to co-create portfolio companies. The studio has launched six portfolio companies spanning disease detection, workflow automation, patient engagement, and real-world data, and reports a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies.

Product overview

Aegis Ventures is a NYC-based venture studio that builds AI-native healthtech companies. The company operates a portfolio of six distinct AI-powered healthcare products: Wavelet Medical (non-invasive fetal brain monitoring via EEG), Optain Health (AI retinal imaging and oculomics), Hume AI (emotionally intelligent voice AI), Caregentic (generative AI patient companions), Avandra (real-world imaging data network), and Ascertain (workflow automation AI). These products collectively address disease detection, patient engagement, data monetization, and operational efficiency across healthcare settings.

Differentiator

Problem solved

Functional benefit

Brands

  • Wavelet: AI-powered fetal brain monitoring platform enabling real-time detection of neurological distress in fetuses through non-invasive EEG technology.
  • Ascertain
  • Avandra
  • Caregentic
  • Hume
  • Optain

Products and services

  • Aegis Ventures Venture Studio NYC-based venture studio that combines deep healthcare insights, aligned capital, and proprietary access to customers through the 14-health-system Aegis Digital Consortium to build and scale AI-native healthtech companies. The studio reports having launched six portfolio companies and a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies collectively.
  • Optain Health AI-backed retinal screening platform that combines AI, retinal imaging, and oculomics to enable non-invasive, rapid assessment of eye and cardiovascular conditions. Detects diabetic retinopathy, glaucoma, macular degeneration, and CVD with >90% accuracy across 10+ diseases in under 60 seconds, deployed across US, EU, UK, Australia, and New Zealand.
  • Hume AI Emotionally intelligent voice AI platform that analyzes vocal emotional signals in real time and adapts tone to respond with expressive, lifelike speech. Empathic Voice Interface (EVI) and Octave text-to-speech engine power emotionally aware voice interactions for mental health, customer service, education, and conversational AI.
  • Caregentic GenAI companion platform that serves as a 24/7 extension of care teams, deploying autonomous AI agents that execute complex clinical and administrative workflows including appointment scheduling, billing questions, care journey navigation, and clinical support via SMS, phone, and web, integrated with EHR systems.
  • Avandra Real-world imaging data platform that enables compliant access to high-quality, standardized imaging (CT, MRI, PET, Ultrasound) from leading health systems to accelerate AI model development for pharma, biotech, and medical AI developers.
  • Ascertain AI agents platform that automates healthcare workflows, transforms operations, and ushers in the workforce of the future for healthcare administration and prior authorization.

Quantifiable outcome

  • 100% seed to Series A conversion across 5 portfolio companies launched
  • +9 more outcomes

Companies that use Aegis Ventures

Customer profile

Named customers10 records

Segments1 record

Ideal customer profiles3 records

Aegis Ventures technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability11 records

Feature6 records

Aegis Ventures partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and key.

  • Wavelet MedicalcoreStrategic or Co-development Partner · 14 April 2026Aegis Ventures entered a co-creation partnership with Wavelet Medical to commercialize a non-invasive, AI-powered fetal EEG monitoring platform developed at Yale. The partnership aims to scale the technology globally, with clinical trials underway at three U.S. sites. Wavelet Medical is a portfolio company spun out of Yale with $7M in seed funding.
  • Bunny EllerinkeyOthers · 6 April 2026Bunny Ellerin appointed as Chief Ecosystem Officer at Aegis Ventures. She leads end-to-end founder and ecosystem development, sourcing top entrepreneurial talent, building the EIR and operator network, and driving strategic relationships across healthcare. Previously co-founded and led Digital Health New York (DHNY).
  • Northwell HealthcoreStrategic or Co-development PartnerNorthwell Health is a core member of the Aegis Digital Consortium, collaborating to advance healthcare innovation by combining leading clinical, technology, and business resources. Northwell works with Aegis to fast-track creation of validated solutions that solve important challenges across the enterprise and can be replicated with health systems across the country.
  • Memorial Hermann Health SystemcoreStrategic or Co-development PartnerMemorial Hermann views innovation as a disciplined pathway to solve real operational and clinical problems. The Aegis Digital Consortium provides a valuable forum for pragmatic insight-sharing and peer learning among health systems, helping shape scalable solutions to shared challenges.
  • Indiana University HealthcoreStrategic or Co-development PartnerIndiana University Health participates in the Aegis Digital Consortium to partner with like-minded health systems in building and investing in new solutions at scale. Together they address common problems and create new businesses that will transform healthcare.
  • Endeavor HealthcoreStrategic or Co-development PartnerEndeavor Health has a rigorous intake requirement which Aegis consistently meets. They are adopting, piloting, or co-developing with most of the portfolio companies and have swapped out incumbents for Aegis solutions.
  • UPMC EnterprisescoreStrategic or Co-development PartnerUPMC Enterprises' partnership with the Digital Consortium enables building deep relationships with peer health system leaders, navigating healthcare challenges together, and collaborating to develop meaningful solutions and scale innovative companies.
  • The Ohio State University Wexner Medical CentercoreStrategic or Co-development PartnerOSU Wexner's mission to drive innovative healthcare transformation aligns with the Aegis Digital Consortium. Through the consortium, they collaborate with other health systems to develop new solutions to help solve challenges facing the healthcare industry.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Aegis Ventures competitors and assessment

Company assessment

Direct peers

  • Redesign Health: Healthcare-focused venture studio that has launched 50+ healthcare companies. Directly comparable to Aegis in model (studio, not fund), vertical focus (healthcare), and company-creation approach, though Redesign has broader sector coverage and a larger capital base.
  • Atomic: Venture studio that builds and funds companies from inception across multiple sectors. Directly comparable studio model to Aegis, though Atomic is more generalist in sector focus and lacks Aegis's healthcare-vertical depth and health system consortium.
  • Founder Factory: Global venture studio that builds startups in partnership with corporates. Comparable studio model to Aegis with corporate-partner-led company creation; differs in sector focus (broader) and lacks Aegis's healthcare-specialized health system consortium.

Broad incumbents

  • General Catalyst: Major venture firm with deep healthcare focus (Health Assurance thesis, committed $750M+ to healthcare) and a creation-oriented approach. Overlaps with Aegis in healthcare AI investment and in working closely with health systems, but operates primarily as a traditional fund rather than a studio.
  • Andreessen Horowitz (a16z Bio/Health): Tier-1 venture firm with a dedicated Bio/Health fund. Competes with Aegis for healthcare AI founder relationships and portfolio investments; offers founders brand prestige and large check sizes that the studio model must counter with embedded customer access.
  • Optum Ventures: Corporate venture arm of UnitedHealth Group focused on healthcare AI and digital health. Comparable in healthcare vertical and willingness to co-create with health system customers; competes for the same founder pool and AI-health deals.
  • Khosla Ventures: Large venture firm with significant healthcare and AI exposure. Competes for healthcare AI deal flow and offers founders a different value proposition (broad sector network vs. Aegis's vertical healthcare studio model with health system consortium).
  • Lux Capital: Science and technology-focused venture firm with healthcare AI portfolio (including AI-native healthtech companies). Comparable in backing technical founders in healthcare AI; differs from Aegis's venture-studio structure and health-system consortium model.

Emerging players

  • SpringTide Ventures: Healthtech-focused venture firm investing in AI-enabled healthcare companies. Comparable healthcare-vertical focus and AI-native investment thesis; differs from Aegis in operating as a traditional fund rather than a venture studio.
  • Flare Capital Partners: Healthcare-focused venture firm investing in early-stage healthtech and digital health companies. Comparable in healthcare vertical and early-stage focus; differs from Aegis's studio model with embedded health system consortium.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Aegis Ventures social profiles

Digital presence

Aegis Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aegis Ventures leadership team

Management profile

Number of profiles

Profiles18 records

Aegis Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aegis Ventures M&A and investment

M&A and investment

M&A

Investments10 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aegis Ventures

What does Aegis Ventures do?

Aegis Ventures is a NYC-based venture studio that builds and scales AI-native healthtech companies. It combines deep healthcare insights, aligned capital, and proprietary customer access through a consortium of 14 leading health systems (the Aegis Digital Consortium) to co-create portfolio companies. The studio has launched six portfolio companies spanning disease detection, workflow automation, patient engagement, and real-world data, and reports a 100% seed-to-Series A conversion rate with over $200M raised by portfolio companies.

Is Aegis Ventures a public or private company?

Aegis Ventures is a private company. It is classified as corporate owned and is currently operating.

When was Aegis Ventures founded?

Aegis Ventures was founded in 2021. It employs 11 to 50 people.

Where is Aegis Ventures based?

Aegis Ventures is headquartered in New York, United States, in the North America region.

How does Aegis Ventures make money?

One revenue line is on record: venture Studio / Equity Ownership.

Who are Aegis Ventures's main competitors?

Direct peers on record are Redesign Health, Atomic and Founder Factory. Broad incumbents are General Catalyst, Andreessen Horowitz (a16z Bio/Health), Optum Ventures, Khosla Ventures and Lux Capital. Emerging players are SpringTide Ventures and Flare Capital Partners.

Does Aegis Ventures have an API?

No public API is recorded for Aegis Ventures.

What industry is Aegis Ventures in?

Aegis Ventures's product category is venture studio services. Its primary akta.pro industry code is FSANAHAC, Corporate Venture Studios & Incubators (Build/launch ventures), with a secondary code of FSANAHAI, Corporate Innovation & Technology Scouting Units (with investment mandate). Its NAICS code is 52394 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
HIT ConsultantReimagining Medical Devices in the AI Era: The Three Structural Shifts Driving Venture-Scale GrowthAegis Ventures released a whitepaper analyzing how the medical device sector has historically captured only 2% to 3% of U.S. healthcare venture capital despite representing a $200 billion annual market, with exit timelines spanning 12 to 17 years. The report identifies three structural shifts driven by AI integration: expanding total addressable markets through multi-application hardware platforms, enabling generalists to perform specialist-level diagnostics, and building compounding data moats that create defensible competitive advantages. The paper highlights portfolio companies Optain Health and Wavelet Medical as proof points demonstrating how AI-native medical devices can overcome traditional venture capital constraints.PR NewswireAegis Ventures Releases New Whitepaper on Why AI Could Unlock Larger Venture Outcomes in MedtechAegis Ventures released a whitepaper titled "Medical Devices in the AI Era" arguing that AI-driven structural shifts—including expanding total addressable markets, enabling generalists to perform specialist-level tasks, and building compounding data advantages—are poised to unlock larger venture-scale outcomes in medtech after decades of underperformance, with medical devices representing only 2–3% of overall venture investment despite healthcare's growing share of U.S. VC. The whitepaper cites Aegis portfolio companies Optain Health, which uses AI-powered retinal imaging for early disease detection in primary care settings, and Wavelet Medical, which uses AI to analyze fetal EEG signals through the mother's abdomen to identify signs of fetal distress, as examples of this emerging category.FinSMEsWavelet Medical Raises $7M in Seed FundingWavelet Medical, a New Haven-based healthcare startup, raised $7M in seed funding from Aegis Ventures. The company, founded by Liz Golden and others, develops an AI-powered non-invasive fetal EEG platform to detect neurological distress. It is currently being tested at three clinical sites and preparing for expanded trials.PR NewswireAegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal MedicineWavelet Medical has partnered with Aegis Ventures to commercialize a non-invasive, AI-powered fetal EEG monitoring platform developed at Yale, backed by $7 million in seed funding. The technology directly measures fetal brain activity through the mother's abdomen to detect neurological distress in real time, addressing limitations of traditional heart rate monitoring which is indeterminate in up to 85% of births. The partnership aims to scale the technology globally, with clinical trials currently underway at three U.S. sites, potentially redefining the standard of care in fetal medicine.FierceHealthcareWavelet Medical, Aegis Ventures partner on first AI non-invasive fetal EEG monitoring platformWavelet Medical and Aegis Ventures have partnered to co-create and scale the first AI-powered non-invasive fetal EEG monitoring platform, designed to detect fetal brain distress in real-time and reduce preventable brain injuries at birth and unnecessary Caesarean sections. The platform has secured $7 million in seed funding and is currently being tested at three clinical sites — Yale University, LA General Hospital, and Korea's Yonsei University Health System — with approximately 300 patients enrolled, aiming to expand to five to seven U.S. hospitals in urban and rural areas.citybizAegis Ventures Appoints Bunny Ellerin as Chief Ecosystem OfficerAegis Ventures, a New York-based venture studio focused on AI-native healthtech companies, announced the appointment of Bunny Ellerin as Chief Ecosystem Officer. Ellerin previously served as Co-Founder and CEO of Digital Health New York (DHNY), where she launched the DHNY Summit and the New York Digital Health 100. In her new role, she will lead founder and ecosystem development, including sourcing entrepreneurial talent, managing an Entrepreneur-in-Residence network, and building strategic relationships across health systems, life sciences, payers, and other industry stakeholders.PR NewswireAegis Ventures Welcomes Digital Health Leader Bunny Ellerin as Chief Ecosystem OfficerAegis Ventures, a New York-based venture studio focused on AI-native healthtech companies, announced the appointment of Bunny Ellerin as Chief Ecosystem Officer. Ellerin previously co-founded and led Digital Health New York (DHNY), where she established the DHNY Summit and the New York Digital Health 100. In her new role, she will lead ecosystem development, entrepreneur sourcing, and strategic relationships across health systems, life sciences, payers, and other industry stakeholders.Pulse 2.0Avandra Acquires DatCard And Sorna To Create The World’s Largest Medical Imaging PlatformAvandra Health announced the acquisition of DatCard Systems and Sorna Corporation, creating what it claims is the world's largest medical imaging platform serving both clinical care and research innovation. The acquisitions bring together two established companies with over 4,800 PacsCube installations globally and significant presence in academic medical centers, including more than half of National Cancer Institute sites. Avandra, founded in 2024 by Aegis Ventures, plans to operate all three entities independently while expanding investment in product development and customer support.FierceHealthcareYale New Haven, Keck Medicine of USC and Hartford HealthCare join Aegis Ventures' digital consortiumYale New Haven Health System, Keck Medicine of USC, and Hartford HealthCare have joined Aegis Ventures' digital consortium, expanding the collaborative network to 14 regional health systems. The expanded group aims to co-develop, invest in, and deploy AI-powered health tech solutions to address common operational pain points and drive revenue diversification. Two startups are set to launch this fall as part of the consortium's accelerated pipeline.PR NewswireAegis Ventures Welcomes Healthcare Leaders John Driscoll and Cris Ross as Venture PartnersAegis Ventures, a NYC-based healthcare venture studio, announced the appointment of John Driscoll and Cris Ross as Venture Partners. Driscoll, formerly CEO of CareCentrix and President of Castlight Health and Medco, brings experience spanning Walgreens, Surescripts, and board roles at Waystar Corporation and UConn Health, while Ross, former CIO of Mayo Clinic with prior roles at CVS Health and Optum, led the clinic's EHR convergence and AI initiatives with Google and Microsoft. The executives will help evaluate new company creation opportunities and advise portfolio companies on commercialization and health system integration.